California Public Employees Retirement System’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-27,500
Closed -$2.12M 2266
2021
Q1
$2.12M Hold
27,500
﹤0.01% 1983
2020
Q4
$1.65M Sell
27,500
-1,308
-5% -$65.3K ﹤0.01% 2125
2020
Q3
$1.24M Buy
28,808
+1,640
+6% +$71.2K ﹤0.01% 2124
2020
Q2
$1.13M Buy
27,168
+3,789
+16% +$182K ﹤0.01% 2151
2020
Q1
$1.01M Sell
23,379
-33,509
-59% -$1.75M ﹤0.01% 2002
2019
Q4
$3.15M Buy
56,888
+43,409
+322% +$2.13M ﹤0.01% 1764
2019
Q3
$468K Buy
13,479
+2,038
+18% +$91.1K ﹤0.01% 2591
2019
Q2
$461K Buy
11,441
+3,441
+43% +$112K ﹤0.01% 2562
2019
Q1
$263K Buy
+8,000
New +$189K ﹤0.01% 2823

Other funds holding KRYS

California Public Employees Retirement System's KRYS Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Krystal Biotech (KRYS) in Q2 2021, closing a stake of 27,500 shares — an estimated $2.12M sold.

California Public Employees Retirement System first reported a position in KRYS in Q1 2019 and held it in 9 quarters. The position peaked at $3.15M in Q4 2019. 113 funds tracked by Wall St. Rank hold KRYS as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Krystal Biotech position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 27,500 Krystal Biotech shares in Q2 2021, an estimated $2.12M.
  • California Public Employees Retirement System first reported a position in Krystal Biotech in Q1 2019 and held it in 9 quarters.
  • California Public Employees Retirement System's Krystal Biotech position peaked at $3.15M in Q4 2019.
  • 113 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.